Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial.
Gao L, Zhang Y, Wang S, Kong P, Su Y, Hu J, Jiang M, Bai H, Lang T, Wang J, Liu L, Yang T, Huang X, Liu F, Lou S, Liu Y, Zhang C, Liu H, Gao L, Liu J, Zhu L, Wen Q, Chen T, Wang P, Rao J, Mao M, Wang C, Duan X, Luo L, Peng X, Cassady K, Zhong JF, Zhang X. Gao L, et al. Among authors: luo l. J Clin Oncol. 2020 Dec 20;38(36):4249-4259. doi: 10.1200/JCO.19.03277. Epub 2020 Oct 27. J Clin Oncol. 2020. PMID: 33108244 Free PMC article. Clinical Trial.
Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS Management.
Li S, Wang X, Yuan Z, Liu L, Luo L, Li Y, Wu K, Liu J, Yang C, Li Z, Wang D, Shen L, Ye X, He J, Han C, Wang Y, Zhang D, Dong Y, Fang L, Chen Y, Sersch M, Cao WW, Wang S. Li S, et al. Among authors: luo l. Clin Cancer Res. 2021 Mar 1;27(5):1242-1246. doi: 10.1158/1078-0432.CCR-20-1271. Epub 2020 Nov 24. Clin Cancer Res. 2021. PMID: 33234511
CD7 targeted "off-the-shelf" CAR-T demonstrates robust in vivo expansion and high efficacy in the treatment of patients with relapsed and refractory T cell malignancies.
Li S, Wang X, Liu L, Liu J, Rao J, Yuan Z, Gao L, Li Y, Luo L, Li G, Li Z, Li S, He J, Zhang L, Chen L, Huang W, Yin P, Li C, Li X, Wang Y, Dong Y, Zhang D, Zang Q, Chen Y, Shen L, Li W, Cao W, Zhang X, Wang S. Li S, et al. Among authors: luo l. Leukemia. 2023 Nov;37(11):2176-2186. doi: 10.1038/s41375-023-02018-4. Epub 2023 Sep 12. Leukemia. 2023. PMID: 37700087
Stable engraftment, as well as graft versus host disease-free and relapse-free survival brought by the combination of CD7 targeted universal chimeric antigen receptor-T, and donor hemopoietic stem cells: Indication of a case report.
Li S, Yuan Z, Liu L, Li Y, Luo L, Peng L, Xu M, Yin P, Chen Y, Li X, Zang Q, Zhang X, Wang S. Li S, et al. Among authors: luo l. EJHaem. 2024 May 15;5(3):584-588. doi: 10.1002/jha2.914. eCollection 2024 Jun. EJHaem. 2024. PMID: 38895056 Free PMC article.
Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial.
Li S, Ling S, Wang D, Wang X, Hao F, Yin L, Yuan Z, Liu L, Zhang L, Li Y, Chen Y, Luo L, Dai Y, Zhang L, Chen L, Deng D, Tang W, Zhang S, Wang S, Cai Y. Li S, et al. Among authors: luo l. Cell Stem Cell. 2024 Jul 5;31(7):961-973.e8. doi: 10.1016/j.stem.2024.04.021. Epub 2024 May 16. Cell Stem Cell. 2024. PMID: 38759653 Free article. Clinical Trial.
Light-Driven Hybrid Nanoreactor Harnessing the Synergy of Carboxysomes and Organic Frameworks for Efficient Hydrogen Production.
Yang J, Jiang Q, Chen Y, Wen Q, Ge X, Zhu Q, Zhao W, Adegbite O, Yang H, Luo L, Qu H, Del-Angel-Hernandez V, Clowes R, Gao J, Little MA, Cooper AI, Liu LN. Yang J, et al. Among authors: luo l. ACS Catal. 2024 Dec 6;14(24):18603-18614. doi: 10.1021/acscatal.4c03672. eCollection 2024 Dec 20. ACS Catal. 2024. PMID: 39722887 Free PMC article.
11,107 results
You have reached the last available page of results. Please see the User Guide for more information.